secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ocean Biomedical, Inc. (OCEA)
CIK:        0001869974
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001641172-25-005788
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01, 5.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Ocean Biomedical receives Nasdaq delisting notice, plans to appeal; expands into energy and crypto
--------------------------------------------------------------------------------

- Nasdaq determined OCEA common stock will be delisted and trading suspended effective April 24, 2025.
- Company intends to appeal the delisting determination within 15 days but warns no guarantee of success.
- Director Jake Kurtis resigned immediately on April 22, 2025 to pursue other interests.
- Strategic expansion into power infrastructure and cryptocurrency treasury (Bitcoin and Solana) announced.
- No specific financial commitments, project sizes, or capital sources disclosed for the new sectors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1869974/000164117225005788/0001641172-25-005788-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1869974/000164117225005788/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-005788

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer